Retrospective evaluation of clinical outcomes in subjects with split-thickness skin graft: comparing V.A.C.® therapy and conventional therapy in foot and ankle reconstructive surgeries.
This retrospective study compared the clinical outcomes of negative pressure wound therapy with reticulated open cell foam (NPWT/ROCF) as delivered by Vacuum-Assisted Therapy(®) (V.A.C.(®) Therapy, KCI Licensing Inc., San Antonio, TX) to non-NPWT/ROCF conventional therapy (CT) in split-thickness skin graft (STSG) survival in all patients to determine whether NPWT/ROCF affects the outcome of the graft survival, in terms of overall graft take, duration of graft take, repeated grafts and complications. The authors conducted a 10-year retrospective review of 142 patients admitted to a level I trauma centre and treated with an STSG in foot and ankle reconstructive surgeries. Demographic data, wound etiology, dressing type used, time to graft take, NPWT/ROCF duration, complications and outpatient treatments were analysed. There were significantly fewer repeated STSGs required in the NPWT/ROCF group compared to CT [n = 3 (3·5%) versus n = 9 (16%); P = 0·006]. In assessing safety, there were fewer complications in graft failure (seroma, hematoma and infection) in the NPWT/ROCF group as compared to the CT group at 8·9 months (range: 1-12 months). NPWT/ROCF is an excellent alternative for securing an STSG and is associated with improved graft survival as measured by a reduction in the number of repeated STSGs and graft failure complications.
Blume
Peter A
PA
Anesthesia and Orthopedics and Rehabilitation, Yale School of Medicine, 333 Cedar Street, TMP 3, PO Box 208051, New Haven, CT 06520-8051, USA. peter.b@snet.net
Key
Jonathan J
JJ
Thakor
Pratapji
P
Thakor
Sejal
S
Sumpio
Bauer
B
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D015400:Clinical Nursing Research; D005260:Female; D016523:Foot Ulcer / Q000209:etiology / Q000601:surgery*; D006085:Graft Survival; D006801:Humans; D008297:Male; D008875:Middle Aged; D054843:Negative-Pressure Wound Therapy / Q000379:methods* / Q000451:nursing; D011182:Postoperative Care / Q000379:methods* / Q000451:nursing; D012189:Retrospective Studies; D017592:Skin Care / Q000379:methods* / Q000451:nursing; D016038:Skin Transplantation / Q000009:adverse effects / Q000451:nursing; D013529:Surgical Wound Dehiscence / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome; D014945:Wound Healing
J Vasc Surg. 2006 Nov;44(5):1029-37; discussion 1038
17000077
Ostomy Wound Manage. 2004 Mar;50(3):52-8
15206090
Ann Plast Surg. 2007 May;58(5):573-6
17452846
Lancet. 2005 Nov 12;366(9498):1704-10
16291063
J Am Podiatry Assoc. 1983 Feb;73(2):79-85
6338096
Vestn Khir Im I I Grek. 1986 Sep;137(9):18-21
3787969
Sov Med. 1984;(2):108-10
6719198
Ann Plast Surg. 1997 Jun;38(6):553-62
9188970
Wound Repair Regen. 2009 Mar-Apr;17(2):192-9
19320887
Ann Plast Surg. 1997 Jun;38(6):563-76; discussion 577
9188971
Plast Reconstr Surg. 2006 Aug;118(2):390-7; discussion 398-400
16874208
Ann Vasc Surg. 2003 Nov;17(6):645-9
14534844
Plast Reconstr Surg. 2004 Oct;114(5):1086-96; discussion 1097-8
15457017
Diabetes Care. 2008 Apr;31(4):631-6
18162494
Arch Surg. 2002 Aug;137(8):930-3; discussion 933-4
12146992
Ann Surg. 2006 Nov;244(5):700-5
17060762
Surg Forum. 1966;17:487-9
5331833
J Wound Care. 2008 Feb;17(2):71-8
18389832
Ostomy Wound Manage. 1999 Nov;45(11):41-50
10687657
Ann Plast Surg. 1998 May;40(5):453-7
9600426
Clin Podiatr Med Surg. 2000 Oct;17(4):561-98
11070796
J Plast Reconstr Aesthet Surg. 2007;60(6):672-81
17485058
Am J Clin Dermatol. 2005;6(3):185-94
15943495
Ann Plast Surg. 2001 Nov;47(5):547-51
11716268
Head Neck. 2007 Jun;29(6):573-6
17252598
Plast Reconstr Surg. 2004 Sep 15;114(4):917-22
15468399